An Entity of Type: chemical substance, from Named Graph: http://dbpedia.org, within Data Space: dbpedia.org

Levormeloxifene (INN; developmental code names 6720-CDRI, NNC-460020) is a selective estrogen receptor modulator (SERM) which was being developed as an alternative to estrogen replacement therapy for the treatment and prevention of postmenopausal bone loss but did not complete development and hence was never marketed. The development was stopped because of a high incidence of gynecological side effects during clinical trials. Levormeloxifene is the levorotatory enantiomer of ormeloxifene, which, in contrast, has been marketed, though rather as a hormonal contraceptive.

Property Value
dbo:abstract
  • Levormeloxifene (INN; developmental code names 6720-CDRI, NNC-460020) is a selective estrogen receptor modulator (SERM) which was being developed as an alternative to estrogen replacement therapy for the treatment and prevention of postmenopausal bone loss but did not complete development and hence was never marketed. The development was stopped because of a high incidence of gynecological side effects during clinical trials. Levormeloxifene is the levorotatory enantiomer of ormeloxifene, which, in contrast, has been marketed, though rather as a hormonal contraceptive. (en)
dbo:casNumber
  • 78994-23-7
dbo:chEMBL
  • 301327
dbo:fdaUniiCode
  • 9512UKZ352
dbo:pubchem
  • 35805
dbo:thumbnail
dbo:wikiPageExternalLink
dbo:wikiPageID
  • 5736573 (xsd:integer)
dbo:wikiPageLength
  • 3393 (xsd:nonNegativeInteger)
dbo:wikiPageRevisionID
  • 1092008447 (xsd:integer)
dbo:wikiPageWikiLink
dbp:c
  • 30 (xsd:integer)
dbp:casNumber
  • 78994 (xsd:integer)
dbp:chembl
  • 301327 (xsd:integer)
dbp:chemspiderid
  • 32935 (xsd:integer)
dbp:h
  • 35 (xsd:integer)
dbp:iupacName
  • 1 (xsd:integer)
dbp:n
  • 1 (xsd:integer)
dbp:o
  • 3 (xsd:integer)
dbp:pubchem
  • 35805 (xsd:integer)
dbp:smiles
  • OCCN5CCCC5 (en)
dbp:stdinchi
  • 1 (xsd:integer)
dbp:stdinchikey
  • XZEUAXYWNKYKPL-WDYNHAJCSA-N (en)
dbp:synonyms
  • Levomeloxifene; 6720-CDRI; NNC-460020 (en)
dbp:unii
  • 9512 (xsd:integer)
dbp:verifiedfields
  • changed (en)
dbp:verifiedrevid
  • 462091315 (xsd:integer)
dbp:width
  • 225 (xsd:integer)
dbp:wikiPageUsesTemplate
dct:subject
gold:hypernym
rdf:type
rdfs:comment
  • Levormeloxifene (INN; developmental code names 6720-CDRI, NNC-460020) is a selective estrogen receptor modulator (SERM) which was being developed as an alternative to estrogen replacement therapy for the treatment and prevention of postmenopausal bone loss but did not complete development and hence was never marketed. The development was stopped because of a high incidence of gynecological side effects during clinical trials. Levormeloxifene is the levorotatory enantiomer of ormeloxifene, which, in contrast, has been marketed, though rather as a hormonal contraceptive. (en)
rdfs:label
  • Levormeloxifene (en)
owl:sameAs
prov:wasDerivedFrom
foaf:depiction
foaf:isPrimaryTopicOf
is dbo:wikiPageWikiLink of
is foaf:primaryTopic of
Powered by OpenLink Virtuoso    This material is Open Knowledge     W3C Semantic Web Technology     This material is Open Knowledge    Valid XHTML + RDFa
This content was extracted from Wikipedia and is licensed under the Creative Commons Attribution-ShareAlike 3.0 Unported License
  NODES